In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria
暂无分享,去创建一个
[1] P. Turner,et al. AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] J. Bellido,et al. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. , 2003 .
[3] E. Goldstein,et al. In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria , 2003, Antimicrobial Agents and Chemotherapy.
[4] E. Goldstein,et al. In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates , 2003, Antimicrobial Agents and Chemotherapy.
[5] J. L. Muñoz Bellido,et al. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. , 2003, International journal of antimicrobial agents.
[6] Ronald N. Jones,et al. In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species. , 2002, Diagnostic microbiology and infectious disease.
[7] G. Funke,et al. Natural Antibiotic Susceptibility of Recently Established Coryneform Bacteria , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[8] Albert Balows,et al. Manual of Clinical Microbiology, 7th ed. , 2000 .
[9] F. Soriano,et al. In Vitro Susceptibilities of Aerobic and Facultative Non-Spore-Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials , 1998, Antimicrobial Agents and Chemotherapy.
[10] M. Collins,et al. Actinomyces europaeus sp. nov., isolated from human clinical specimens. , 1997, International journal of systematic bacteriology.
[11] B. Schneider,et al. Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes. , 1997, The Journal of antimicrobial chemotherapy.
[12] G. Eliopoulos,et al. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria , 1997, Antimicrobial agents and chemotherapy.
[13] K. Bernard,et al. Clinical microbiology of coryneform bacteria , 1997, Clinical microbiology reviews.